Detalhe da pesquisa
1.
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature
; 616(7957): 534-542, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046095
2.
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Nature
; 616(7957): 525-533, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046096
3.
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists.
Histopathology
; 84(3): 429-439, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957137
4.
An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis.
J Mol Cell Cardiol
; 174: 25-37, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336008
5.
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
Br J Cancer
; 125(9): 1210-1216, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489586
6.
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
Oncologist
; 26(2): e306-e315, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145902
7.
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.
Mod Pathol
; 33(5): 792-801, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740722
8.
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
Future Oncol
; 15(12): 1363-1383, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758227
9.
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.
Thorax
; 71(2): 177-84, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26530085
10.
BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.
Histopathology
; 64(4): 547-56, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266897
11.
Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions.
J Clin Pathol
; 77(2): 135-139, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604178
12.
Association between pathologic response and survival after neoadjuvant therapy in lung cancer.
Nat Med
; 30(1): 218-228, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903504
13.
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.
Thorax
; 73(Suppl 1): i1-i30, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444986
14.
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing.
Lung Cancer
; 184: 107293, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683526
15.
Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee.
J Thorac Oncol
; 18(4): 447-462, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36503176
16.
Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.
Mod Pathol
; 25(12): 1574-83, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22814311
17.
Personalized medicine for lung cancer: new challenges for pathology.
Histopathology
; 60(4): 531-46, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21916947
18.
Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management.
Virchows Arch
; 481(3): 335-350, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857102
19.
Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.
Virchows Arch
; 481(3): 351-366, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857103
20.
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
J Thorac Oncol
; 17(3): 362-387, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808341